RCKT Latest Press Releases

-- August 10, 2026 --

Rocket Pharmaceuticals Reports Second Quarter 2026 Financial Results and Highlights Recent Progress Business Wire 4:00 PM

-- August 3, 2026 --

Rocket Pharmaceuticals Announces Positive Clinical Safety Update from Initial Three Patients Treated with RP-A501 Under Modified Phase 2 Protocol for Danon Disease Business Wire 7:00 AM

-- June 12, 2026 --

Rocket Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $180 Million Business Wire 7:00 AM

-- May 28, 2026 --

Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences Business Wire 7:00 AM

-- May 7, 2026 --

Rocket Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Recent Progress Business Wire 4:00 PM

-- April 28, 2026 --

Rocket Pharmaceuticals Announces $180 Million Sale of Priority Review Voucher Business Wire 7:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software